Life Sciences and Innovation Council (LSIC)

LSIC Fact Sheet

LSIC Membership Application

Please note that application cannot be saved before submission and allow yourself 10-15 minutes to complete it. Please click here if you prefer a printable PDF application.


Life Sciences and Innovation Council Main Contacts:

Major pharmaceutical companies are all growing their businesses by being members of NJAMHAA's Life Sciences and Innovation Council and tapping into New Jersey's vast behavioral healthcare market. NJAMHAA is the leading trade association in New Jersey representing the needs of nonprofit behavioral health provider organizations.


Alkermes is a fully integrated global biopharmaceutical company and leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases.

Mark Stephan
Regional Director of Access and Reimbursement



BioNJ is The Gateway to Health, a powerful network of 400 Members representing research-based life sciences companies and other contributors to a vibrant ecosystem where science is supported, companies are created, drugs are developed and patients are paramount. Because Patients Can’t Wait, we are dedicated to propelling this rich, innovation ecosystem forward in New Jersey and beyond to help stimulate the discovery, development and commercialization of therapies and cures and save and improve lives and lessen the burden of illness and disease to society.

Debbie Hart - President and CEO



Healthcare Institute of New Jersey

The HealthCare Institute of New Jersey is a trade association for the research-based pharmaceutical and medical technology industry in New Jersey. Founded in 1997, the Institute serves as a unified voice for the industry and seeks to build awareness of this industry’s impact on New Jersey’s quality of life and economic well-being.

Megan Fielder - Government Affairs Associate


Johnson & Johnson North American Pharmaceuticals/Janssen Pharmaceuticals, Inc. 

The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology, immunology, neuroscience, and cardiovascular and metabolic diseases. Driven by their commitment to patients, the company develops sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders.  

Chris Womack - Healthcare Policy and Advocacy Director

Otsuka America Pharmaceutical, Inc.

In North America, Otsuka Pharmaceutical Co., Ltd. operates three pharmaceutical companies dedicated to creating and promoting new products and innovative solutions for better health worldwide, with a focus on four specialty areas: neuroscience, oncology, cardio-renal, and medical devices.

Mark DiMaio - Assoc. Director, Mental Health Advocacy and Policy

Pfizer, Inc.

Pfizer is committed to applying science and our global resources to improve health and well-being at every stage of life. They strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them.

Dean Gianarkis - Medical Outcomes Specialist



Pharma-Care provides state-of-the-art consultant pharmacy services, making individualized recommendations in the interest of what is best for each patient based on clinical evaluation and current literature.

Harry Thibodeau - Vice President, State Operations


Sunovion Pharmaceuticals, Inc.

Sunovion is a leading pharmaceutical company dedicated to discovering, developing, and bringing to market therapeutic products that advance the science of medicine to improve the lives of patients, their families, and communities. We specialize in treatments that help people challenged by disorders of the central nervous system and respiratory ailments.

Katrina Iserman - Director, State Government Affairs

Powered by